| CorMedix (Amex: CRMD) Neutrolin(R) Could Generate Significant Value - BiotechStockTrader.com |
|
|
BiotechStockTrader.com Before its bankruptcy, BioLink received $1.5 million in R&D funding from a large dialysis company called Fresenius Medical Care Holdings Inc., |